Sermorelin Injection Dosage

Sermorelin injection dosing protocols can vary between providers, but most physician-guided programs follow a standard range based on clinical guidelines and patient response. The most commonly prescribed sermorelin injection dosage falls between 200mcg and 500mcg per day, administered as a single subcutaneous injection before bed following the sermorelin injection instructions provided by your telehealth provider. Your prescribing provider will determine the right starting dose for you based on your current IGF-1 levels and overall health profile. Before reviewing dosing specifics, it helps to understand the full range of sermorelin injection benefits you can expect from treatment.

Sermorelin injection dosing may be adjusted depending on your primary treatment goal. While all patients start within the standard dosage range, providers may fine-tune the protocol based on whether you are focused on anti-aging, body composition, recovery, or sleep improvement.

Sermorelin injection dosage is not static — your provider will monitor your progress and adjust your protocol based on how your body responds. Most adjustments happen after your first follow-up lab work, typically at the 8–12 week mark. IGF-1 levels are the primary marker used to evaluate whether your current sermorelin injection dosage is producing the desired hormonal response. If levels are too low, your dose may be increased. If IGF-1 is within optimal range, your provider may maintain or slightly reduce the dose to avoid over-stimulation.

Sermorelin injection dosage is generally prescribed within the same standard range for both men and women — typically 200mcg to 500mcg per day — but the specific starting dose and protocol adjustments can vary based on individual hormone levels, age, and treatment goals rather than gender alone.

Men pursuing sermorelin therapy for lean muscle support and athletic recovery may be prescribed doses toward the higher end of the standard range, particularly if baseline IGF-1 levels are significantly below optimal. Women using sermorelin for sleep quality, skin health, and anti-aging goals often respond well at lower starting doses, with adjustments made based on how their IGF-1 levels respond over the first 8–12 weeks of treatment.

In both cases, the prescribing physician takes a personalized approach to sermorelin injection dosage. Age is a significant factor — older patients may require slightly higher doses to achieve the same IGF-1 response as younger patients, simply because natural HGH production declines with age. Body weight and composition also play a role in determining the appropriate starting dose. Your provider will review all of these factors during your initial consultation and set a sermorelin injection dosage that is appropriate for your specific profile before adjusting based on follow-up lab results.

One of the advantages of sermorelin therapy over synthetic HGH is that your body's natural feedback system provides a built-in safety mechanism — if IGF-1 levels rise too high, the pituitary gland naturally reduces its response. That said, following your prescribed sermorelin injection dosage correctly is still important for both safety and effectiveness.

The most common dosage-related mistake patients make is self-adjusting their dose without consulting their provider. Increasing your sermorelin injection dosage beyond what was prescribed in an attempt to accelerate results is not recommended and can lead to side effects including water retention, joint discomfort, and temporary numbness or tingling. These side effects are typically associated with excessive IGF-1 stimulation and resolve when dosage is reduced.

Never inject a higher dose than prescribed and never inject more frequently than your protocol specifies without provider approval. If you feel your current sermorelin injection dosage is not producing results, contact your telehealth provider to schedule a follow-up lab review rather than adjusting on your own. A proper IGF-1 test will give your provider the data they need to make a safe and effective dose adjustment based on how your body is actually responding to treatment.

Many patients who experience strong results from sermorelin therapy choose to continue treatment beyond the initial 3–6 month protocol. Long term sermorelin injection dosage typically shifts to a maintenance phase once IGF-1 levels have reached an optimal range and the patient has achieved their primary treatment goals.

During the maintenance phase, your provider may reduce your sermorelin injection dosage slightly or adjust your injection frequency from daily to 5 days per week. Some providers recommend periodic cycling — for example, taking sermorelin for 5 days and resting for 2 — to prevent pituitary receptor desensitization over extended use. These adjustments are designed to sustain the benefits of treatment at the lowest effective dose rather than maintaining the same aggressive protocol indefinitely.

Long term patients typically have follow-up lab reviews every 3–6 months to monitor IGF-1 levels and ensure the maintenance sermorelin injection dosage continues to produce the desired hormonal response. If levels drop below optimal range during a maintenance phase, the provider may temporarily increase the dose back to the original treatment level before tapering again. The goal of long term sermorelin therapy is to maintain the improvements achieved during the initial protocol while keeping the treatment as sustainable and cost effective as possible for the patient.

Common questions about sermorelin injection dosing protocols, timing, and how your provider determines the right dose for your treatment plan.

Get prescribed online, shipped to your door, and supported by licensed medical providers every step of the way.

Understanding sermorelin injection dosage starts with knowing what to look for in a physician-guided program.